anti-PTK6 Protein tyrosine Kinase 6 (PTK6) Antikörper

The protein encoded by PTK6 is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Zusätzlich bieten wir Ihnen PTK6 Proteine (15) und PTK6 Kits (11) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
PTK6 5753 Q13882
PTK6 366275  
PTK6 20459 Q64434
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-PTK6 Antikörper auf antikoerper-online.de

Showing 10 out of 157 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Pferd Kaninchen Unkonjugiert WB <b>WB Suggested Anti-PTK6 Antibody Titration: </b>0.2-1 ug/ml<br><b>ELISA Titer: </b>1:1562500<br><b>Positive Control: </b>HepG2 cell lysate 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
358,51 €
Details
Human Kaninchen Unkonjugiert EIA, IHC (p), WB 0.4 mL Anmelden zum Anzeigen 7 bis 9 Tage
407,00 €
Details
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-hPTK6-E26 Pab (ABIN392105) in A375 cell line lysate (35 µg/lane). hPTK6-E26(arrow) was detected using the purified polyclonal antibody (1:50 dilution). Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. BC = breast carcinoma. HC = hepatocarcinoma 400 μL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Human Kaninchen Unkonjugiert IF, ELISA, WB Western blot analysis of extracts from 293 cells treated with EGF 200ng/ml 30', using Breast Tumor Kinase (Phospho-Tyr447) Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of NIH-3T3 cells, using Breast Tumor Kinase (Phospho-Tyr447) Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 6 bis 8 Tage
342,86 €
Details
Human Kaninchen Unkonjugiert ELISA, WB Western blot analysis of extracts from LOVO cells, using Breast Tumor Kinase Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 6 bis 8 Tage
342,86 €
Details
Human Kaninchen Unkonjugiert IF, ELISA Immunofluorescence analysis of NIH-3T3 cells, using Breast Tumor Kinase (Ab-447) Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Anmelden zum Anzeigen 6 bis 8 Tage
342,86 €
Details
Human Kaninchen Unkonjugiert IF (p), IHC (p), WB   100 μL Anmelden zum Anzeigen 18 bis 22 Tage
326,42 €
Details
Human Maus Unkonjugiert ELISA, WB Figure 1: Western blot analysis using PTK6 mouse mAb against Hela (1), A549 (2) and MCF-7 (3) cell lysate. 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
507,79 €
Details
Pferd Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 11 bis 14 Tage
653,02 €
Details
Human Kaninchen Unkonjugiert ELISA, IF, WB 100 μL Anmelden zum Anzeigen 13 Days
154,33 €
Details

PTK6 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human , , ,
,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,
Mouse (Murine) , ,


, , , , , , , , , , , , , , , ,

Am meisten referenzierte anti-PTK6 Antikörper

  1. Human Polyclonal PTK6 Primary Antibody für IF, WB - ABIN519483 : Foudah, Sallam, Akl, El Sayed: Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors. in European journal of medicinal chemistry 2014 (PubMed)
    Show all 3 Pubmed References

  2. Human Monoclonal PTK6 Primary Antibody für IHC (p), ELISA - ABIN519484 : Akl, Ayoub, Mohyeldin, Busnena, Foudah, Liu, Sayed: Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. in PLoS ONE 2014 (PubMed)
    Show all 2 Pubmed References

  3. Human Monoclonal PTK6 Primary Antibody für ELISA, WB - ABIN2869234 : Liu, Zhang, Zhong, Li, Liu, Lin, Wu, Zeng: Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma. in Journal of translational medicine 2013 (PubMed)

  4. Human Polyclonal PTK6 Primary Antibody für IHC (p), WB - ABIN392105 : Derry, Prins, Ray, Tyner: Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. in Oncogene 2003 (PubMed)
    Show all 2 Pubmed References

  5. Human Polyclonal PTK6 Primary Antibody für IF (p), IHC (p) - ABIN1713614 : Akl, Foudah, Ebrahim, Meyer, El Sayed: The marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling. in Marine drugs 2014 (PubMed)

  6. Human Monoclonal PTK6 Primary Antibody für ELISA - ABIN966923 : Ottilie, Raulf, Barnekow, Hannig, Schartl: Multiple src-related kinase genes, srk1-4, in the fresh water sponge Spongilla lacustris. in Oncogene 1992 (PubMed)
    Show all 3 Pubmed References

  7. Human Monoclonal PTK6 Primary Antibody für ELISA, WB - ABIN969373 : Wilks: Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. in Proceedings of the National Academy of Sciences of the United States of America 1989 (PubMed)
    Show all 4 Pubmed References

Weitere Antikörper gegen PTK6 Interaktionspartner

Human PTK6 Protein tyrosine Kinase 6 (PTK6) Interaktionspartner

  1. Expression of PTK6 in established tumors may maintain the epithelial phenotype, preventing tumor progression.

  2. analysis of recombinant PTK6 kinase domain by x-ray crystallography reveals details of its binding to inhibitors

  3. The crystal structure of the kinase domain of human PTK6 has been reported.

  4. PTK6 mRNA and protein levels were elevated in cervical squamous cell cancer and the elevated cytoplasmic expression of PTK6 was associated with tumor grade and short patient survival.

  5. PELP1 (zeige PELP1 Antikörper) interacted with GR to activate Brk expression.

  6. PTK6 prolongs S-phase and increases the ability of gemcitabine to cause DNA damage in vitro and in vivo

  7. BRK expression in a majority of CC can interact with RTK, augmenting growth and interfering with proliferation inhibitors (SAM68 (zeige KHDRBS1 Antikörper)). Therapeutically targeting BRK function (in addition to RTK) should be of benefit for CC treatment.

  8. Additive impact of HER2 (zeige ERBB2 Antikörper)-/PTK6-RNAi on interactions with HER3 (zeige ERBB3 Antikörper) or IGF-1R (zeige IGF1R Antikörper) leads to reduced breast cancer progression

  9. overexpression or knockdown of PTK6 or ERK1/2 effectively removed the inhibition of S1P-induced migration by miR-17.

  10. Establishment of cross talk between PTK6 and CagA (zeige S100A8 Antikörper) by functional studies may further elucidate the underlying biology of H. pylori-mediated gastric cancer

Mouse (Murine) PTK6 Protein tyrosine Kinase 6 (PTK6) Interaktionspartner

  1. PTK6 may act as a novel mediator of TNFalpha (zeige TNF Antikörper)/IFNgamma intestinal epithelial permeability during inflammatory injury, and miR (zeige MLXIP Antikörper)-93 may protect intestinal epithelial barrier function, at least in part, by targeting PTK6

  2. PTK6 prolongs S-phase and increases the ability of gemcitabine to cause DNA damage in vitro and in vivo

  3. Ptk6 promotes ERBB2 (zeige ERBB2 Antikörper)-induced mammary gland tumorigenesis in the mouse.

  4. Protein tyrosine kinase 6 has a role in mediating TNFalpha (zeige TNF Antikörper)-induced endothelial barrier dysfunction

  5. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT (zeige AKT1 Antikörper).

  6. expression of Brk/PTK6 in non-transformed mammary epithelial cells mediates p38 MAPK (zeige MAPK14 Antikörper) phosphorylation and promotes increased cellular survival, delayed involution, and latent tumor formation.

  7. a novel function for PTK6 at the plasma membrane

  8. PTK6 promotes STAT3 (zeige STAT3 Antikörper) activation in the colon following injection of the carcinogen azoxymethane and regulates STAT3 (zeige STAT3 Antikörper) activity in mouse colon tumors.

  9. AKT (zeige AKT1 Antikörper) is a direct substrate of PTK6 and AKT (zeige AKT1 Antikörper) tyrosine residues 315 and 326 are phosphorylated by PTK6.

  10. PTK6 associates with nuclear and cytoplasmic beta-catenin (zeige CTNNB1 Antikörper) and inhibits beta-catenin (zeige CTNNB1 Antikörper)- and T-cell factor (TCF (zeige HNF4A Antikörper))-mediated transcription.

PTK6 Antigen-Profil

Protein Überblick

The protein encoded by this gene is a cytoplasmic nonreceptor protein kinase which may function as an intracellular signal transducer in epithelial tissues. Overexpression of this gene in mammary epithelial cells leads to sensitization of the cells to epidermal growth factor and results in a partially transformed phenotype. Expression of this gene has been detected at low levels in some breast tumors but not in normal breast tissue. The encoded protein has been shown to undergo autophosphorylation. Alternative splicing results in multiple transcript variants.

Genbezeichner und Symbole assoziert mit PTK6

  • PTK6 protein tyrosine kinase 6 (PTK6) Antikörper
  • protein tyrosine kinase 6 (PTK6) Antikörper
  • protein tyrosine kinase 6 (Ptk6) Antikörper
  • PTK6 protein tyrosine kinase 6 (Ptk6) Antikörper
  • BRK Antikörper
  • Sik Antikörper
  • tks Antikörper
  • Tksk Antikörper

Bezeichner auf Proteinebene für PTK6

PTK6 protein tyrosine kinase 6 , protein-tyrosine kinase 6-like , breast tumor kinase , protein-tyrosine kinase 6 , protein-tyrosine kinase BRK , tyrosine-protein kinase BRK , protein tyrosine kinase 6 , src-related intestinal kinase , tyrosine kinase identified from skin

GENE ID SPEZIES
100060532 Equus caballus
100438236 Pongo abelii
100589028 Nomascus leucogenys
5753 Homo sapiens
366275 Rattus norvegicus
20459 Mus musculus
529814 Bos taurus
Ausgewählte Anbieter für anti-PTK6 (PTK6) Antikörper
Haben Sie etwas anderes gesucht?